South Korea

South Korea is a recognized hub for clinical research in the Asian region, with more clinical trials recorded than any other Asian country between 2001 and 2012.

George Clinical In South Korea

South Korea is a recognized hub for clinical research in the Asia Pacific region, with more clinical trials recorded than any other Asian country between 2001 and 2017.

There are many government support structures for conducting research in Korea. This, coupled with a sophisticated infrastructure, a large population and a market size of approximately USD 20 billion, Korea attracts a large number of industry sponsors. Strong government support exists to encourage clinical trials in Korea.

Korea is the leading clinical trial destination in the Asian region. Between 2001 and 2012, Korea had the highest number of clinical trials compared to other Asian countries. Approximately 45 % of clinical trials in Korea are multinational trials.  There is strong government support to develop Korean clinical trial capacity and capability, and in particular to train clinical trial professionals and develop world-class sites.

The regulatory body responsible for administering the regulatory framework in Korea is the Ministry of Food and Drug Safety (MFDS). The MFDS has a policy of encouraging global trial participation and simultaneous global registration, which is evident from the many government incentives to promote international clinical trials. Only sites accredited by the MFDS may conduct clinical trials. There are more than 180 accredited sites in Korea.

What are the benefits of conducting clinical trials in South Korea?

  • Leading clinical trial destination in the Asian region
  • Between 2001 and 2017, Korea had the highest number of trials compared to other Asian countries
  • Approximately 80% of clinical trials in Korea are multinational trials
  • Fastest study start-up times in Asia, with well-defined regulatory and review processes

Why is the country attractive for sponsors to conduct clinical trials?

  • Accelerate study start-up timeline
  • Well-established clinical research sites and well infrastructure
  • Globally recognized KOLs
  • Good track records in recruitment

Why is George Clinical the CRO of choice for our sponsors in Korea?

  • Well-established site network
  • Experienced team on local regulations requirement
  • Engagement with key opinion leaders (oncology and renal)

Contact

Address:
4th FL, S&M Building
120 Myeongdal-ro, Seocho-dong
Seocho-gu, Seoul 06658
Republic of Korea

Email: info@georgeclinical.com

Details

Population 51 million
Official Language Korean, English (widely taught in junior high and high school)
Hospital Records Language Korean (English commonly used in professional settings)
Electronic Hospital Records Approximately 80% of sites approved for clinical trials have an electronic medical record system. The rest is in the process of transition.
Site Network Only accredited sites are able to carry out human clinical trials. As of August 2017, there are 184 accredited sites in Korea.
In-country services Project Management
Clinical Operations
Regulatory Services
GDP – per capita (US $) $32,775
Health Expenditures 7.2% of GDP